Man Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $76.9M | Buy |
232,369
+88,159
| +61% | +$30M | 0.16% | 162 |
|
|
2025
Q4 | $57.3M | Buy |
144,210
+72,537
| +101% | +$32.1M | 0.11% | 215 |
|
|
2025
Q3 | $32.7M | Buy |
71,673
+63,564
| +784% | +$25.9M | 0.06% | 354 |
|
|
2025
Q2 | $2.64M | Buy |
8,109
+1,038
| +15% | +$287K | 0.01% | 1302 |
|
|
2025
Q1 | $1.91M | Sell |
7,071
-9,311
| -57% | -$2.39M | 0.01% | 1379 |
|
|
2024
Q4 | $3.85M | Sell |
16,382
-93,421
| -85% | -$24.6M | 0.01% | 1105 |
|
|
2024
Q3 | $30.2M | Sell |
109,803
-8,107
| -7% | -$2.11M | 0.09% | 314 |
|
|
2024
Q2 | $28.7M | Sell |
117,910
-92,325
| -44% | -$14.6M | 0.08% | 316 |
|
|
2024
Q1 | $31.4M | Buy |
210,235
+167,345
| +390% | +$27.9M | 0.08% | 289 |
|
|
2023
Q4 | $8.21M | Buy |
+42,890
| New | +$7.31M | 0.02% | 748 |
|
|
2023
Q3 | – | Sell |
-50,679
| Closed | -$9.67M | – | 985 |
|
|
2023
Q2 | $9.63M | Buy |
+50,679
| New | +$10M | 0.03% | 634 |
|
|
2023
Q1 | – | Sell |
-1,841
| Closed | -$387K | – | 265 |
|
|
2022
Q4 | $438K | Buy |
1,841
+523
| +40% | +$112K | ﹤0.01% | 1546 |
|
|
2022
Q3 | $264K | Buy |
+1,318
| New | +$251K | ﹤0.01% | 1704 |
|
|
2022
Q2 | – | Sell |
-1,374
| Closed | -$195K | – | 562 |
|
|
2022
Q1 | $224K | Buy |
+1,374
| New | +$209K | ﹤0.01% | 1896 |
|
|
2021
Q4 | – | Sell |
-3,443
| Closed | -$650K | – | 1936 |
|
|
2021
Q3 | $650K | Buy |
+3,443
| New | +$646K | ﹤0.01% | 1469 |
|
|
2021
Q1 | – | Sell |
-19,992
| Closed | -$2.6M | – | 1837 |
|
|
2020
Q4 | $2.6M | Sell |
19,992
-1,921
| -9% | -$257K | 0.01% | 1104 |
|
|
2020
Q3 | $3.19M | Sell |
21,913
-36,971
| -63% | -$5.25M | 0.01% | 1024 |
|
|
2020
Q2 | $8.72M | Buy |
58,884
+56,184
| +2,081% | +$7.57M | 0.04% | 411 |
|
|
2020
Q1 | $294K | Sell |
2,700
-515
| -16% | -$59.4K | ﹤0.01% | 1388 |
|
|
2019
Q4 | $370K | Sell |
3,215
-8,255
| -72% | -$823K | ﹤0.01% | 1640 |
|
|
2019
Q3 | $923K | Sell |
11,470
-25,482
| -69% | -$2.02M | ﹤0.01% | 1455 |
|
|
2019
Q2 | $2.68M | Buy |
36,952
+16,890
| +84% | +$1.3M | 0.01% | 1209 |
|
|
2019
Q1 | $1.88M | Sell |
20,062
-2,017
| -9% | -$169K | 0.01% | 1361 |
|
|
2018
Q4 | $1.61M | Sell |
22,079
-3,281
| -13% | -$252K | 0.01% | 1297 |
|
|
2018
Q3 | $2.22M | Sell |
25,360
-9,810
| -28% | -$987K | 0.01% | 1376 |
|
|
2018
Q2 | $3.46M | Buy |
35,170
+32,770
| +1,365% | +$3.25M | 0.01% | 1120 |
|
|
2018
Q1 | $286K | Buy |
+2,400
| New | +$309K | ﹤0.01% | 1853 |
|
Other funds holding ALNY
VPM
VCM
